Imveliso ye-EUR kwi-Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38-7/59774-06-0/1009- 14-9/705-60-2

Inkampani yethu ibeka ugxininiso kulawulo, ukwaziswa kwabasebenzi abanetalente, kunye nokwakhiwa kwezakhiwo zabasebenzi, izama ngamandla ukuphucula umgangatho kunye nokuqonda uxanduva lwabasebenzi.Inkampani yethu iphumelele iSitifiketi se-IS9001 kunye neSatifikethi se-CE saseYurophu seZitishi ze-EUR kwi-Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Siyakukhuthaza ukuba ubambe njengoko kudala sifuna amaqabane kwilinge lethu.Siqinisekile ukuba uya kutyhila ukwenza inkampani nathi kungekuphela nje ukuba neziqhamo kodwa nengeniso.Silungiselele ukukunika oko ukufunayo.
Inkampani yethu ibeka ugxininiso kulawulo, ukwaziswa kwabasebenzi abanetalente, kunye nokwakhiwa kwezakhiwo zabasebenzi, izama ngamandla ukuphucula umgangatho kunye nokuqonda uxanduva lwabasebenzi.Inkampani yethu iphumelele iSiqinisekiso se-IS9001 kunye neSatifikethi se-CE saseYurophuChina 1451 83 8 kunye CAS 1451 83 8, Kule mihla iimveliso zethu zithengisa kulo lonke ilizwe nakwamanye amazwe enkosi ngenkxaso eqhelekileyo kunye nabatsha abathengi.Sinikezela ngemveliso ekumgangatho ophezulu kunye nexabiso elikhuphisanayo, bamkele abathengi abaqhelekileyo nabatsha basebenzisane nathi!

I-1-Bromo-2-methoxy-3-nitro-benzene isetyenziswa njengendawo ephakathi ye-Eltrombopag.
I-Eltrombopag, ephuhliswe yi-GlaxoSmithKline (GSK) e-UK kwaye kamva iphuhliswe ngokudibeneyo kunye ne-Novartis eSwitzerland, yeyokuqala kwaye ivunyiwe kuphela i-molecule encinci ye-non peptide TPO receptor agonist emhlabeni.I-Eltrombopag yavunywa yi-US FDA kwi-2008 yonyango lwe-idiopathic thrombocytopenic purpura (ITP), kunye ne-2014 yonyango lwe-anemia ye-aplastic enzima (AA).Ikwalichiza lokuqala elavunywa yi-US FDA kunyango lwe-AA kwiminyaka engama-30 yakutsha nje.
NgoDisemba 2012, i-US FDA ivume i-Eltrombopag yonyango lwe-thrombocytopenia kwizigulane ezine-hepatitis C engapheliyo (CHC), ukwenzela ukuba izigulane ze-hepatitis C ezine-prognosis embi ngenxa yokubala kweplatelet ephantsi inokuqala kwaye igcine unyango oluqhelekileyo lwe-interferon kwizifo zesibindi.NgoFebruwari3, 2014, i-GlaxoSmithKline yabhengeza ukuba i-FDA inike isiqinisekiso sonyango lwe-Eltrombopag kunyango lwe-hemopenia kwizigulane ezine-chemicalbook aplastic anemia (SAA) ezinzima ezingazange ziphendule ngokupheleleyo kwi-immunotherapy.Ngo-Agasti 24, i-2015, i-US FDA ivume i-Eltrombopag yonyango lwe-thrombocytopenia kubantu abadala kunye nabantwana abaneminyaka eyi-1 kunye nangaphezulu kunye ne-immune immune thrombocytopenia (ITP) abangenayo impendulo eyaneleyo kwi-corticosteroids, i-immunoglobulins okanye i-splenectomy.NgoJanuwari4, 2018, i-Eltrombopag yavunywa ukuba ibhalwe e-China kunyango lwe-immune immune thrombocytopenia (ITP).

Inkampani yethu ibeka ugxininiso kulawulo, ukwaziswa kwabasebenzi abanetalente, kunye nokwakhiwa kwezakhiwo zabasebenzi, izama ngamandla ukuphucula umgangatho kunye nokuqonda uxanduva lwabasebenzi.Inkampani yethu iphumelele iSitifiketi se-IS9001 kunye neSatifikethi se-CE saseYurophu seZitishi ze-EUR kwi-Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Siyakukhuthaza ukuba ubambe njengoko kudala sifuna amaqabane kwilinge lethu.Siqinisekile ukuba uya kutyhila ukwenza inkampani nathi kungekuphela nje ukuba neziqhamo kodwa nengeniso.Silungiselele ukukunika oko ukufunayo.
Iivenkile zomzimveliso weChina 1451 83 8 kunye CAS 1451 83 8, Kule mihla iimveliso zethu zithengisa kulo lonke ilizwe nakwamanye amazwe enkosi ngenkxaso eqhelekileyo kunye nabatsha abathengi.Sinikezela ngemveliso ekumgangatho ophezulu kunye nexabiso elikhuphisanayo, bamkele abathengi abaqhelekileyo nabatsha basebenzisane nathi!